| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A 2024 global report on national policies, programmes, and progress towards hepatitis C elimination: findings from 33 hepatitis elimination profiles
|
Hiebert-Suwondo, Lindsey
|
|
|
10 |
7 |
p. 685-700
|
artikel
|
| 2 |
A 2024 global report on national policy, programmes, and progress towards hepatitis B elimination: findings from 33 hepatitis elimination profiles
|
Hiebert-Suwondo, Lindsey
|
|
|
10 |
7 |
p. 671-684
|
artikel
|
| 3 |
Alcohol and health: time for Europe to sober up
|
The Lancet Gastroenterology & Hepatology,
|
|
|
10 |
7 |
p. 605
|
artikel
|
| 4 |
A plasma-based multimetabolite biomarker for early detection of pancreatic cancer
|
Earl, Julie
|
|
|
10 |
7 |
p. 607-609
|
artikel
|
| 5 |
Correction to Lancet Gastroenterol Hepatol 2025; 10: 418–30
|
|
|
|
10 |
7 |
p. e9
|
artikel
|
| 6 |
Digestive Disease Week 2025
|
Gomersall, Bethany
|
|
|
10 |
7 |
p. 618
|
artikel
|
| 7 |
EASL Congress 2025
|
Thomas, Hugh
|
|
|
10 |
7 |
p. 619
|
artikel
|
| 8 |
Etrasimod as a treatment for eosinophilic oesophagitis (VOYAGE): a double-blind, placebo-controlled, randomised, phase 2 trial
|
Dellon, Evan S
|
|
|
10 |
7 |
p. 622-633
|
artikel
|
| 9 |
Etrasimod in the treatment of eosinophilic oesophagitis: a promising match?
|
von Arnim, Ulrike
|
|
|
10 |
7 |
p. 606-607
|
artikel
|
| 10 |
Hypovolaemic phlebotomy and bloodless liver surgery
|
Moris, Dimitrios
|
|
|
10 |
7 |
p. 613
|
artikel
|
| 11 |
Hypovolaemic phlebotomy and bloodless liver surgery – Authors' reply
|
Carrier, François M
|
|
|
10 |
7 |
p. 613-614
|
artikel
|
| 12 |
India's continued response to tackling metabolic disorders and non-communicable diseases
|
Prasad, Manya
|
|
|
10 |
7 |
p. 616-617
|
artikel
|
| 13 |
Julia Mayerle: circling around the pancreas
|
Van Epps, Heather
|
|
|
10 |
7 |
p. 620
|
artikel
|
| 14 |
Prevalence of hepatitis C virus seropositivity and active infection in a Rohingya refugee population in Cox's Bazar camps, Bangladesh: a cross-sectional study
|
Schramm, Birgit
|
|
|
10 |
7 |
p. 648-657
|
artikel
|
| 15 |
Refining clinical success metrics in EUS-guided gastroenterostomy
|
Vanella, Giuseppe
|
|
|
10 |
7 |
p. 615-616
|
artikel
|
| 16 |
Reservations for Nine: A Doctor's Family Confronts Cancer
|
Sherwood-Martin, Hollie
|
|
|
10 |
7 |
p. 621
|
artikel
|
| 17 |
Sexual health and young people living with chronic hepatitis B: adopting a treatment as prevention framework
|
Block, Suzanne J
|
|
|
10 |
7 |
p. 609-612
|
artikel
|
| 18 |
The role of [18F]FDG and [18F]FCH PET-CT in hepatocellular carcinoma with cirrhosis
|
Yang, Hanwen
|
|
|
10 |
7 |
p. 614
|
artikel
|
| 19 |
The role of [18F]FDG and [18F]FCH PET-CT in hepatocellular carcinoma with cirrhosis – Author's reply
|
Nault, Jean-Charles
|
|
|
10 |
7 |
p. 614-615
|
artikel
|
| 20 |
Toripalimab plus bevacizumab versus sorafenib as first-line treatment for advanced hepatocellular carcinoma (HEPATORCH): a randomised, open-label, phase 3 trial
|
Shi, Yinghong
|
|
|
10 |
7 |
p. 658-670
|
artikel
|
| 21 |
Validation of two plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma (METAPAC): a prospective, multicentre, investigator-masked, enrichment design, phase 4 diagnostic study
|
Mahajan, Ujjwal M
|
|
|
10 |
7 |
p. 634-647
|
artikel
|
Tijdschrift beschrijving